Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,321,000 | 4,367,000 | 1,300,000 | 12,013,000 | 8,249,000 |
| Depreciation Amortization | 3,463,000 | 1,746,000 | 5,642,000 | 3,773,000 | 2,062,000 |
| Income taxes - deferred | -285,000 | 44,000 | 2,406,000 | -407,000 | -72,000 |
| Accounts receivable | -1,005,000 | -499,000 | -616,000 | -241,000 | -452,000 |
| Other Working Capital | -1,978,000 | -2,819,000 | 11,258,000 | -968,000 | -2,293,000 |
| Other Operating Activity | 1,169,000 | 767,000 | 1,066,000 | 781,000 | 1,191,000 |
| Operating Cash Flow | $9,685,000 | $3,606,000 | $21,056,000 | $14,951,000 | $8,685,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -663,000 | -638,000 | -1,447,000 | -1,313,000 | -1,124,000 |
| Net Acquisitions | -222,000 | -82,000 | -35,151,000 | -34,646,000 | -34,072,000 |
| Purchase Of Investment | -951,000 | -548,000 | -6,153,000 | -5,798,000 | -5,227,000 |
| Sale Of Investment | 743,000 | 341,000 | 28,117,000 | 27,511,000 | 27,320,000 |
| Other Investing Activity | -33,000 | 2,000 | -234,000 | -117,000 | -80,000 |
| Investing Cash Flow | $-1,126,000 | $-925,000 | $-14,868,000 | $-14,363,000 | $-13,183,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 27,000 | 26,000 | 869,000 | 4,760,000 | 2,635,000 |
| Debt Issued | 3,000 | 2,000 | 8,992,000 | 4,465,000 | 4,464,000 |
| Debt Repayment | -9,000 | -8,000 | -1,777,000 | -1,024,000 | -15,000 |
| Common Stock Issued | 162,000 | 66,000 | 1,062,000 | 854,000 | 719,000 |
| Common Stock Repurchased | -1,589,000 | -1,444,000 | -6,358,000 | -5,543,000 | -5,232,000 |
| Dividend Paid | -4,668,000 | -2,253,000 | -8,943,000 | -6,687,000 | -4,433,000 |
| Other Financing Activity | -2,570,000 | -2,359,000 | -1,518,000 | -961,000 | -205,000 |
| Financing Cash Flow | $-8,644,000 | $-5,970,000 | $-7,673,000 | $-4,136,000 | $-2,067,000 |
| Exchange Rate Effect | -170,000 | 104,000 | 337,000 | 297,000 | 191,000 |
| Beginning Cash Position | 17,824,000 | 17,824,000 | 18,972,000 | 18,972,000 | 18,972,000 |
| End Cash Position | 17,569,000 | 14,639,000 | 17,824,000 | 15,721,000 | 12,598,000 |
| Net Cash Flow | $-255,000 | $-3,185,000 | $-1,148,000 | $-3,251,000 | $-6,374,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,685,000 | 3,606,000 | 21,056,000 | 14,951,000 | 8,685,000 |
| Capital Expenditure | -1,533,000 | -658,000 | -3,279,000 | -2,039,000 | -1,249,000 |
| Free Cash Flow | 8,152,000 | 2,948,000 | 17,777,000 | 12,912,000 | 7,436,000 |